XML 55 R48.htm IDEA: XBRL DOCUMENT v3.24.3
Deferred Royalty Obligation related to the Sale of Future Royalties - Schedule of Royalty Obligation transaction (Details) - Vaxcyte, Inc.
$ in Thousands
 9 Months Ended
Sep. 30, 2024
USD ($)
Deferred Royalty Obligation [Line Items]  
Liability related to sale of future Vaxcyte royalties - beginning balance $ 149,114
Non-cash interest expense associated with the sale of future Vaxcyte royalties 22,380
Amortization of issuance costs 473
Liability related to the sale of future Vaxcyte royalties - ending balance $ 171,967